Xeloda



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 19.3%
Breast Cancer 13.2%
Colon Cancer 11.5%
Breast Cancer Metastatic 8.7%
Colorectal Cancer 7.4%
Drug Use For Unknown Indication 6.5%
Gastric Cancer 5.5%
Rectal Cancer 5.4%
Colorectal Cancer Metastatic 3.7%
Colon Cancer Metastatic 3.3%
Hypertension 2.5%
Rectal Cancer Metastatic 2.1%
Pain 1.8%
Large Intestine Carcinoma 1.7%
Pancreatic Carcinoma 1.6%
Metastatic Gastric Cancer 1.4%
Neoplasm Malignant 1.3%
Prophylaxis 1.1%
Colon Cancer Recurrent 1.1%
Oesophageal Carcinoma 0.9%
Death 46.9%
Disease Progression 10.8%
Vomiting 7.5%
Palmar-plantar Erythrodysaesthesia Syndrome 5.2%
Diarrhoea 4.6%
Malignant Neoplasm Progression 4.5%
Weight Decreased 2.7%
Stomatitis 2.1%
Thrombocytopenia 1.8%
Nausea 1.6%
White Blood Cell Count Decreased 1.5%
Pyrexia 1.5%
Sepsis 1.3%
Neoplasm Malignant 1.3%
Interstitial Lung Disease 1.2%
Mucosal Inflammation 1.2%
Skin Exfoliation 1.1%
Metastases To Liver 1.1%
Renal Failure 1.1%
Intestinal Obstruction 1.0%
Secondary
Breast Cancer 21.4%
Product Used For Unknown Indication 11.7%
Breast Cancer Metastatic 9.4%
Colon Cancer 6.5%
Drug Use For Unknown Indication 6.4%
Gastrooesophageal Cancer 6.0%
Colon Cancer Metastatic 5.0%
Rectal Cancer 4.6%
Gastric Cancer 4.2%
Prophylaxis 4.0%
Colorectal Cancer Metastatic 3.9%
Colorectal Cancer 3.2%
Rectal Cancer Metastatic 2.7%
Hypertension 2.4%
Pain 1.7%
Cancer Pain 1.7%
Metastatic Gastric Cancer 1.7%
Large Intestine Carcinoma 1.4%
Metastases To Bone 1.1%
Pancreatic Carcinoma 1.1%
Vomiting 14.0%
Death 13.1%
Palmar-plantar Erythrodysaesthesia Syndrome 12.1%
Diarrhoea 7.7%
Disease Progression 7.1%
Pulmonary Embolism 5.1%
Stomatitis 5.1%
Weight Decreased 4.8%
Rash 4.1%
White Blood Cell Count Decreased 3.8%
Pyrexia 3.6%
Nausea 3.5%
Thrombocytopenia 2.5%
Renal Failure Acute 2.4%
Sepsis 2.3%
Malignant Neoplasm Progression 2.1%
Neuropathy Peripheral 1.9%
Neutropenia 1.8%
Decreased Appetite 1.6%
Fatigue 1.6%
Concomitant
Breast Cancer 32.5%
Metastases To Bone 13.8%
Breast Cancer Metastatic 12.6%
Drug Use For Unknown Indication 6.1%
Premedication 5.5%
Product Used For Unknown Indication 4.8%
Colon Cancer 4.3%
Pain 3.2%
Prophylaxis 2.5%
Hypertension 2.2%
Colorectal Cancer Metastatic 1.6%
Breast Cancer Recurrent 1.6%
Depression 1.4%
Colorectal Cancer 1.3%
Chemotherapy 1.2%
Nausea 1.2%
Cancer Pain 1.1%
Diabetes Mellitus 1.1%
Colon Cancer Metastatic 1.1%
Prophylaxis Of Nausea And Vomiting 1.0%
Vomiting 13.8%
Tooth Extraction 9.7%
Diarrhoea 9.1%
Weight Decreased 8.4%
Nausea 6.8%
Death 6.5%
Rash 5.7%
Pyrexia 4.8%
Osteonecrosis 4.3%
Palmar-plantar Erythrodysaesthesia Syndrome 4.2%
Fatigue 3.8%
Toothache 3.5%
Disease Progression 3.1%
Vision Blurred 3.0%
Stomatitis 2.4%
White Blood Cell Count Decreased 2.3%
Wound Dehiscence 2.3%
Neoplasm Malignant 2.2%
Wound Debridement 2.2%
Malaise 1.9%
Interacting
Colon Cancer Metastatic 13.8%
Hypertension 10.7%
Large Intestine Carcinoma 10.2%
Product Used For Unknown Indication 9.2%
Diabetes Mellitus 7.1%
Atrial Fibrillation 6.1%
Drug Use For Unknown Indication 6.1%
Breast Cancer 4.6%
Anaemia 3.6%
Analgesic Therapy 3.6%
Benign Prostatic Hyperplasia 3.6%
Constipation 3.6%
Colorectal Cancer Metastatic 3.1%
Epilepsy 2.6%
Mitral Valve Incompetence 2.6%
Prophylaxis Of Nausea And Vomiting 2.6%
Breast Cancer Metastatic 2.0%
Colon Cancer Stage Iv 2.0%
Colon Cancer 1.5%
Gastric Cancer 1.5%
White Blood Cell Count Decreased 11.6%
Epilepsy 9.3%
Prothrombin Time Prolonged 9.3%
Faeces Discoloured 7.0%
Palmar-plantar Erythrodysaesthesia Syndrome 7.0%
Subdural Haematoma 7.0%
Toxicity To Various Agents 7.0%
Cough 4.7%
Drug Interaction 4.7%
Pyrexia 4.7%
Rash 4.7%
Stomatitis 4.7%
Bone Marrow Failure 2.3%
Gastrointestinal Haemorrhage 2.3%
Hallucination, Visual 2.3%
International Normalised Ratio Fluctuation 2.3%
International Normalised Ratio Increased 2.3%
Mononeuropathy Multiplex 2.3%
Myocardial Infarction 2.3%
Syncope 2.3%